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A B S T R A C T
Background: Empirical evidence supporting the cost-effectiveness
estimates of particular health care technologies may be limited, or it
may even be missing entirely. In these situations, additional infor-
mation, often in the form of expert judgments, is needed to reach a
decision. There are formal methods to quantify experts’ beliefs,
termed as structured expert elicitation (SEE), but only limited
research is available in support of methodological choices. Perhaps
as a consequence, the use of SEE in the context of cost-effectiveness
modelling is limited. Objectives: This article reviews applications of
SEE in cost-effectiveness modelling with the aim of summarizing
the basis for methodological choices made in each application and
recording the difﬁculties and challenges reported by the authors in
the design, conduct, and analyses. Methods: The methods used
in each application were extracted along with the criteria used to
support methodological and practical choices and any issues or
challenges discussed in the text. Issues and challenges were
extracted using an open ﬁeld, and then categorised and grouped
for reporting. Results: The review demonstrates considerable
heterogeneity in methods used, and authors acknowledge great
methodological uncertainty in justifying their choices. Speciﬁcities
of the context area emerging as potentially important in determin-
ing further methodological research in elicitation are between-
expert variation and its interpretation, the fact that substantive
experts in the area may not be trained in quantitative subjects, that
judgments are often needed on various parameter types, the need
for some form of assessment of validity, and the need for more
integration with behavioural research to devise relevant debiasing
strategies. Conclusions: This review of experiences of SEE high-
lights a number of speciﬁcities/constraints that can shape the
development of guidance and target future research efforts in this
area.
Keywords: Bayesian, cost effectiveness, decision modeling, elicitation,
expert judgment, subjective.
Copyright & 2018, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Introduction
Reimbursement decisions are often supported by model-based
economic evaluation (MBEE) [1]. Uncertainty in the evidence used
to populate these models can result in uncertain cost-effective-
ness estimates [2]. There may be circumstances in which empiri-
cal data are limited (e.g., a cancer product licensed on the basis of
progression-free survival, with limited evidence on survival
impacts) or are missing entirely (e.g., when assessing the value
of a future clinical trial for a medical technology). In these
situations, additional information, often in the form of expert
judgments, reported as a distribution, is needed to reach a
decision. To improve the accountability of the decision-making
process, the procedure used to derive these judgments should be
transparent, with any uncertainty in individual judgments char-
acterized, in addition to between-expert variation [3].
Formal methods to quantify experts’ beliefs exist and are
termed as structured expert elicitation (SEE) [3,4]. Elicitation has
been used in various disciplines including weather forecasting [5]
and food and safety risk assessments [6]. Nevertheless, the
existing methodological research on elicitation, both generic and
discipline-speciﬁc, is inconsistent and noncommittal [7]. Methodo-
logical uncertainties may be one of the main reasons for the
limited use of formal SEE in the context of MBEE. A review of
applications in this area, published in 2013 [8], identiﬁed only a
small number (14) of studies reporting the use of SEE. This review
did not seek to determine the reasons for heterogeneity of
approach, nor did it look at the challenges faced when conducting
SEE to support MBEE and inform directions for future research.
In pursuit of further clarity, this article updates the afore-
mentioned review [8], but instead of reporting the way elicitation
is being used in practice, it focuses on summarizing the basis for
1098-3015$36.00 – see front matter Copyright & 2018, International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
https://doi.org/10.1016/j.jval.2018.01.019
* Address correspondence to: Marta O. Soares, Centre for Health Economics, University of York, Alcuin “A” Block, York YO10 5DD, UK.
E-mail: marta.soares@york.ac.uk.
V A L U E I N H E A L T H 2 1 ( 2 0 1 8 ) 7 1 5 – 7 2 3
methodological choices made in each application (design, con-
duct, and analysis) and the difﬁculties and challenges reported by
the authors. In the Methods section, the methods for identifying
the literature are described and an overview of the contexts in
which SEE was used across studies is made. The sections that
follow discuss choices, challenges, and issues relating to the
design of SEE; conduct of SEE; and analyses of SEE. In detailing
these elements it is necessary to ﬁrst describe the applications
(see the Summary of Applied Studies section and Tables 1–3), and
that is where the similarities exist between this review and the
2013 [8] review, and also where they end. The last section sets out
speciﬁc challenges posed by SEE in MBEE to inform the direction
of future research.
Methods
To identify applications of SEE, the 2013 review [8] was updated
(identifying studies up to April 11, 2017). Further details on the
methods of the search are given in the Appendix in Supplemental
Materials found at https://doi.org/10.1016/j.jval.2018.01.019, but, in
brief, studies were identiﬁed via Ovid SP MEDLINE and, similarly in
the 2013 review [8], were included only if they contained an SEE to
elicit uncertain parameters (in the form of a distribution) to inform
MBEE. Studies conducting preference elicitation(e.g., to generate
utility estimates for health states) were not included.
The methods used in each application were extracted (the
extraction form is reproduced in Tables 1–3, which also present
results) along with the criteria used to support methodological
and practical choices and any issues or challenges discussed in
the text. Issues and challenges were extracted using an open ﬁeld
and then categorized and grouped for reporting.
Results
Summary of Applied Studies
In total, 21 studies were included. Table 1 and the Appendix in
Supplemental Materials provide summary information on each
study and highlight that elicitation has been used mainly when
data on a particular parameter are limited or absent. Four of the
21 applications were applied in an early modeling context, where
there may not be direct clinical experience with the technology of
interest, and 8 evaluated a diagnostic or screening strategy.
Table 2 presents the method of recruiting experts, methods of
elicitation, and methods of aggregation in each of the applied
studies. Table 3 presents how the SEE was conducted, including
mode of administration and use of any software, and also any
analyses that were performed. Each element of the applied
studies is considered, and choices, challenges, and issues dis-
cussed in the following sections.
Aspects Related to the Design of the SEE
Considerations on the design of the SEE were grouped according
to speciﬁcation of the quantities to elicit, selection of experts,
elicitation method, and type of aggregation and weighting of
experts’ judgments.
Speciﬁcation of quantities to elicit
In all applications, experts’ beliefs were sought for only a few
parameters of a decision model, often not elicited directly but
calculated from one or more alternative elicited quantities. For
example, a time-constant transition probability could be
Table 1 – Summary of applications.
Study Type of strategy under
investigation
Was the aim to inform an early
assessment (i.e., R&D) rather
than reimbursement?
Type of parameter(s) elicited
Garthwaite et al.
[14]
Treatment No Event probabilities, time to event,
dependency
Leal et al. [10] Diagnostic/screening No Event probabilities, relative effectiveness,
diagnostic accuracy
Girling et al. [15] Treatment Yes Event probabilities, time to event
Stevenson et al. [16] Prevents transmission No Event probabilities, time to event, relative
effectiveness
Meads et al. [12] Diagnostic/screening Yes Event probabilities, diagnostic accuracy,
minimum important clinical difference
McKenna et al. [19] Treatment No Event probabilities
Haakma et al. [13] Diagnostic/screening Yes Diagnostic accuracy
Stevenson et al. [17] Treatment No Event probabilities, relative effectiveness
Speight et al. [25] Diagnostic/screening No Event probabilities
Sperber et al. [22] Treatment No Event probabilities, relative effectiveness
Brodtkorb [26] Several exercises conducted but insufﬁcient detail reported on each
Colbourn et al. [28] Diagnostic/screening No Event probabilities, relative effectiveness
Soares et al. [9] Treatment No Event probabilities, relative effectiveness
Bojke et al. [18] Treatment No Relative effectiveness, dependency
Cao et al. [11] Diagnostic/screening Yes Relative effectiveness
Fischer et al. [23] Treatment No Counts, time to event
Poncet et al. [27] Diagnostic/screening No Event probabilities
Grigore et al. [24] Treatment No Event probabilities
Wilson et al. [20] Treatment No Event probabilities, relative effectiveness
Meeyai et al. [21] Vaccine No Event probabilities
Grimm et al. [35] Diagnostic/screening No Diffusion†
R&D, research and development.
† Rate of implementation in clinical practice over time.
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indirectly elicited by asking experts for the mean time at which
an event is observed or, alternatively, the proportion of patients
who have an event within a particular time period. In the
applications, the choice of which quantities to elicit was based
on a number of criteria. The ﬁrst was appropriateness for experts.
Parameters in decision models can be complex and may not be
directly observable by experts; to account for this, some of the
studies expressed, for example, relative effectiveness parameters
as probabilities [9–12] or sensitivities and speciﬁcities into prob-
abilities of the true disease status of the patients conditional on
the test results [12]. It may also be more appropriate for different
experts to elicit different quantities (e.g., in one application [10],
geneticists elicited accuracy of a genetic test, and cardiologists
elicited parameters related to disease progression) or, in the
presence of heterogeneity, for a particular quantity to be elicited
separately for population subgroups [12,13].
Table 2 – Experts, method of elicitation, and method of aggregation.
Study Experts and recruitment Approach and method
of elicitation
Aggregation
Type of
experts
Recruitment No. of
experts
VIM
or
FIM
Method
(summaries
elicited)
Aggregation
approach
Weights
used in
main
exercise?
Nature
of
weights
Garthwaite
et al. [14]
NR NR 4 VIM Median and
quartiles
Mathematical No –
Leal et al.
[10]
Clinicians Purposive 6 FIM Four
complementary
intervals
Mathematical No –
Girling
et al. [15]
Clinicians Purposive 5 VIM* NR Consensus – –
Stevenson
et al. [16]
NR NR NR NR NR NR NR NR
Meads et al.
[12]
Clinicians Purposive 21 FIM Chips and bins† Mathematical No –
McKenna
et al. [19]
NR NR 5 FIM Chips and bins Mathematical No –
Haakma
et al. [13]
Clinicians Purposive 14 VIM Mode and 95% CI Mathematical Yes Objective
weights
Stevenson
et al. [17]
Clinicians Purposive 3 VIM Median and
quartiles
Consensus – –
Speight
et al. [25]
Clinicians NR 9 FIM Chips and bins† NR NR
Sperber
et al. [22]
Clinicians NR NR VIM Median and
quartiles
Mathematical Yes, but no
details
provided
Performance-
based
Colbourn
et al. [28]
NR NR 4 VIM Mean and 95% CI Mathematical NR NR
Soares
et al. [9]
Clinicians NR 23 FIM Chips and bins Mathematical No, but
explored
in a pilot
Performance-
based
weights
explored
Bojke et al.
[18]
Clinicians Purposive 5 FIM Chips and bins Mathematical Yes Performance-
based
weights
Cao et al.
[11]
Clinicians NR 2 FIM Mode and one
percentile
Mathematical No –
Fischer
et al. [23]
Clinicians Purposive 19 VIM Median and 80% CI Mathematical No, but
explored
Performance-
based
weights
explored
Poncet
et al. [27]
Clinicians NR 13 FIM Chips and bins Mathematical No –
Grigore
et al. [24]
Clinicians Purposive 7 FIM Chips and bins
þ four
complementary
intervals
Mathematical Yes,
alongside
equal
weighting
Performance-
based
weights
explored
Wilson
et al. [20]
Clinicians þ
policy
strategist
NR 6 NR NR NR NR NR
Meeyai
et al. [21]
Clinicians þ
epidemiologists
NR 10 VIM Mode and
quartiles
Consensus – –
Grimm
et al. [35]
NR NR 3 NR NR Mathematical NR NR
CI, conﬁdence interval; FIM, ﬁxed interval method; NR, not reported; VIM, variable interval method.
*Unclear, but description of results suggests that VIM has been used.
† Includes studies that list the following methods: chips and bins, frequency chart, and histogram method.
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Table 3 – Summary of applications (conduct and analyses).
Study Conduct Analyses
Mode of
administration
Opportunities
for revision
Format/
software
Training Piloting Pooling Fitting Pooled
distribution
used
directly
within the
decision
model?
Garthwaite
et al. [14]
Individual face-
to-face and
remote
(telephone)
interviews
Unclear Interview and
specialized
software
NR No No pooling Independently
elicited
quantities:
NR;
dependency
elicitation:
yes,
generalized
linear model
No, each
expert’s
distributions
used
directly
Leal et al.
[10]
Remote (email)
and individual
face-to-face
interviews
Yes Excel-based NR Yes Linear
pooling
Yes, maximum
likelihood
Yes
Girling
et al. [15]
Group face-to-
face
interviews
Yes NA NR NR – Yes, method
NR
Yes
Stevenson
et al. [16]
NR NR NR NR NR NR NR Yes
Meads et al.
[12]
Group face-to-
face and
individual
face-to-face
interviews
NR Paper Yes NR Linear
pooling
NR No, Bayesian
updating
with
existing
evidence
McKenna
et al. [19]
NR NR Excel-based Yes Yes Linear
pooling
Yes, method
NR
Yes
Haakma
et al. [13]
Individual face-
to-face
interviews
Yes Excel-based NR Yes Linear
pooling
Yes, Project
Evaluation
and Review
Technique
software
Yes
Stevenson
et al. [17]
Group face-to-
face
interviews
Yes NR NR NR NA Yes, least
squares
NR
Speight
et al. [25]
NR NR Paper NR NR NR Yes, method
NR
Yes
Sperber
et al. [22]
Remote
(telephone)
interviews
Yes Excel-based NR Yes Linear
pooling
Yes, least
squares
(EasyFit
software)
NR
Colbourn
et al. [28]
NR NR NR NR NR Predictive
distribution
from
random-
effects
meta-
analysis
Yes, method
NR
Yes
Soares
et al. [9]
Group face-to-
face
interviews
Yes Excel-based Yes Yes Linear
pooling
Yes, method of
moments
No, Bayesian
updating
with
existing
evidence
Bojke et al.
[18]
Individual face-
to-face
interviews
Yes Excel-based Yes NR Linear
pooling
and
random-
effects
meta-
analysis
Yes, method of
moments
Yes
Cao et al.
[11]
NR NR NR NR NR Linear
pooling
Yes (BetaBuster
software)
Yes
continued on next page
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The second criterion related to statistical concerns. The
quantities elicited should be ﬁt-for-purpose not only in informing
decision models (e.g., reﬂecting time dependency), but also in
allowing elicited evidence to be combined with any existing
empirical evidence [9]. Statistical coherence between quantities
elicited should also be ensured [9,14]. For example, when a
number of mutually exclusive outcomes are of relevance, elicit-
ing their probabilities independently (with uncertainty) cannot
guarantee that they sum to 1, but re-expressing parameters as
conditional binomial variables does ensure this [9,14]. In addition,
dependencies may exist between the quantities elicited (e.g.,
correlation between relative effectiveness parameters for alter-
native interventions), between quantities elicited and known
covariates, or between a priori independent quantities that are
elicited from the same expert (e.g., some experts may be prone to
eliciting higher values across the board than others). Of the seven
studies that raised the issue of dependency [9,11,14–18], three did
not deal with it at all [15–17]; two studies re-expressed target
parameters as conditionally independent [9,11] and the remain-
ing two studies explicitly elicited dependency [14,18]. In the
latter, rather than a correlation parameter being elicited directly,
relationships between parameters were captured by asking
experts to express how their judgments would change if values
for other quantities were known. Methods to elicit dependence
directly were, however, generally thought to be complex [9].
The ﬁnal criterion was burden to experts. Burden can be
reduced by limiting the number of target parameters to elicit,
eliciting homogeneous quantities throughout the exercise (e.g.,
all probability parameters) [9], using ﬁlter questions (e.g., “Do you
think X differs from Y?”) [9,19], and not eliciting dependency or
eliciting it only for the covariates identiﬁed by the experts as
relevant [14].
Selection of experts
All applications recruited health care professionals (but not
exclusively [20,21]) on the basis of the following criteria: recog-
nition by peers [10], specialist knowledge or clinical experience
[9,10,13,18,19,22,23], based in the relevant jurisdiction [9,10,18,19],
research experience [10,22,23], and lack of involvement in prod-
uct development [13]. In early technology assessment, applica-
tions have also looked for other factors such as interaction with
colleagues, seen as indicative of the adaptive skills required in
this context.
A number of authors [9,14,24] recognized that health care
professionals are unlikely to have knowledge of elicitation and
may have only sparse quantitative skills. This has been judged by
the authors to compromise normative skills, deﬁned as the ability
to accurately express judgments in a particular quantitative
format, such as probabilities. This has driven the choices made
in designing and conducting the SEE, such as training needs,
method of elicitation, and deﬁnition of the quantities to elicit [9].
Many of the applications have included a varied sample of
experts by recruiting them from a range of relevant specialties
[10,12,20], clinical settings [9,10,20], and geographical areas/coun-
tries [10,23] to capture heterogeneity in beliefs (reﬂecting under-
lying heterogeneity in patient populations) and avoid
dependency between experts [10].
Across the applications, sampling was purposeful: typically,
experts recruited were either collaborators in the research or
identiﬁed by recommendation from clinical colleagues [10,14,18],
by contacting professional associations [24], or at specialist
conferences [15,23]. Sample sizes ranged from 2 [11] to 23 [9]
(Table 2), generally targeting a small but “varied” sample [10]. One
author [22], however, argued that restricting the pool of experts
may amplify biases arising, for example, from shared exposure
Table 3 – continued
Study Conduct Analyses
Mode of
administration
Opportunities
for revision
Format/
software
Training Piloting Pooling Fitting Pooled
distribution
used
directly
within the
decision
model?
Fischer
et al. [23]
Group face-to-
face,
individual
face-to-face,
and remote
(telephone)
interviews
NR Paper Yes Yes Linear
pooling
No, empirical
distribution
used
NR
Poncet
et al. [27]
NR NR NR NR NR Linear
pooling
NR Yes
Grigore
et al. [24]
Individual face-
to-face
interviews
Yes Excel-based Yes Yes Linear
pooling
Yes, method
NR
Yes
Wilson
et al. [20]
NR NR SHELF NR NR NR NR Yes
Meeyai
et al. [21]
NR NR SHELF NR NR NR NR No, Bayesian
updating
with
existing
evidence
Grimm
et al. [35]
NR NR NR NR NR Linear
pooling
Yes, least
squares
Yes
NA, not applicable; NR, not reported; SHELF, Shefﬁeld Elicitation Framework.
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to unrepresentative clinical experience. Many applications
mention constraints to sampling because of resources available
to fund the SEE [22], limited number of relevant experts [10],
or geographic distance [18,22].
Elicitation method
An important requirement for MBEE is the need to elicit uncer-
tainty of experts’ judgments in the form of a distribution. This
implies that a number of summaries need to be elicited for each
quantity to deﬁne the shape of a distribution. To do this, applica-
tions have typically used one of two approaches: ﬁxed interval
method (FIM) [9–12,18,19,24–27] or variable interval method (VIM)
[13,14,17,21–23,28] (Table 2). In an FIM, experts are provided with
ranges of values and asked to assess the probability that the
quantity lies in each. In a VIM, experts are asked to specify values
of the quantity of interest for predeﬁned percentiles of the
distribution. Although one application [10] chose FIM because
the literature suggested that it returns higher variance, it was
more common for authors to consider both approaches. Choices
were justiﬁed on the basis of pilot exercises designed for the
purpose (see later), generic methods research, previous use in
MBEE, and claims of lower burden or intuitiveness for experts.
Applications using VIM elicit either quartiles of the distribution
[14,17,21,22] or credible intervals [13,23,28], and in general ask for a
very limited number of summaries. Studies using FIM often choose
the “chips and bins” method (histogram technique or probability
grid) [9,18,19,25–27]. This method deﬁnes a larger number of
intervals (typically up to 20) and asks the expert to distribute a
ﬁxed number of chips across these intervals. The more chips
placed in a particular interval, the stronger the belief that the true
value of the quantity of interest lies in that interval. Despite many
of the studies arguing for the intuitiveness of the chips and bins
method, a pilot study [13] found that two of the three experts
included preferred eliciting 95% probability intervals. Other FIMs,
which divide the plausible range of values into four or six
complementary or overlapping intervals and ask for quantitative
expression of strength of belief for each, have also been used [10].
Pilot testing among these found that six complementary intervals
resulted in very narrow ranges and that overlapping intervals were
confusing to experts [10]. A separate study [24] comparing the
chips and bins method with the four complementary intervals
method found that the latter required more careful consideration
and, because of that, experts perceived it to be more (face-) valid.
Also, the resulting pooled distributions were wider. Another FIM
application [11] asked experts for a central estimate and elicited
for a single interval. This study was noteworthy because it took a
more frequentist approach by presenting a hypothetical scenario
in which 100 different experiments were conducted and asked
experts how many times in those experiments would they expect
the observed value to be larger than a particular value.
Consensus versus mathematical aggregation, weighting of
experts
Fourteen studies [9-14,18,19,22-24,27,28,35] elicited individually
from experts and aggregated mathematically, three aimed to
achieve consensus among experts [15,17,21], and three others did
not explicitly report the method of aggregation used [16,20,25]
(Table 2).
None of the three studies using consensus were explicit about
the reasons for choosing consensus or the process of achieving it.
Therefore, the following focuses on those using a mathematical
approach.
Authors justify the choice of mathematical aggregation on the
basis of the desirability to reﬂect variation within and between
experts [12], because consensus is known to lead to overconﬁdent
results (i.e., narrow distributions) [10] and because it raises
practical difﬁculties of convening experts and providing experi-
enced facilitation. One pilot study [9] additionally showed that
consensus produced incoherent probability statements (the
median time to healing was greater than the time taken for
70% of patients to heal).
When adopting a mathematical approach there needs to be
some consideration on whether to differentially weight the
responses of individual experts. Most of the applications
reviewed claim insufﬁcient justiﬁcation for generating differ-
ential weights [9,10] and lack of clarity on how to appropriately
generate the weights [9,13,26] and hence apply equal weighting.
Five studies, however, explored unequal weighting, either on the
basis of responses to “seed” questions [9,18,23,24] (performance-
based weighting) or using the clinical background of experts [13]
(objective weighting). Performance-based weighting (commonly
called calibration) typically asks experts to respond to one or
more seed questions known to the analyst (with certainty) but
not the expert. Elicited responses are compared with their known
values to generate the weights, with the most commonly used
method, the classical method [29], considering both accuracy and
informativeness.
Applied studies question the usefulness of calibration and
request further methodological research. Uncertainties relate to
the number and deﬁnition of appropriate seed questions for
particular target questions. For example, one study [9] piloted
four alternative seed questions and found that, when used
separately, these generated divergent weights. In another appli-
cation, responses to eight seed questions generated 0 weights to
17 of the 19 substantive experts—authors expressed discomfort
in discarding so much of the information. A third study [18]
questioned the relevance of seed questions known with certainty
and instead used seeds that were known with uncertainty.
Weights were generated on the basis of the overlap of the elicited
and true distributions.
Experiences with the Conduct of the Exercise
No studies reported major challenges in the conduct of the SEE,
despite the complexity of the task.
Consensus exercises were typically face-to-face, in a group;
mathematical exercises adopted a mix of formats, ranging from
individual interviews to remote completion via email (Table 3).
Convening a group facilitated training and a common under-
standing of the problem [12], but some studies [10,12,14,26]
departed from this format because of time constraints, geo-
graphical limitations, and constraints related to the availability
of experts. One example [9], using a mathematical approach,
elicited 18 uncertain parameters in 2 hours after a 2-hour training
session.
Administration was via bespoke tools using Excel
[9,10,18,19,24,26], paper questionnaires, a generic elicitation pack-
age (the Shefﬁeld Elicitation Framework) [20,21], and a software
package for the elicitation of dependency (Prior Elicitation Graph-
ical Software) [14] (Table 3). Other studies did not specify the
mode of administration. The most common tool, bespoke Excel
applications, had several perceived advantages, including tailor-
ing the presentation to avoid inconsistencies and conditioning
questions on previous responses [9].
Some exercises were explicit about piloting the tool to ensure
clear wording of the questions [9,13,19,22], and most offered
opportunities for revision and/or graphical feedback (Table 3).
Five applications were explicit about training of experts
[9,12,13,18,24] covering overview of the project and of the role
of elicitation [9,12,13,18,24], quantities required and deﬁnitions
[9,12,18,24], explanation and expression of uncertainty [9,13],
consideration of potential biases [9,18,24], use of the elicitation
instrument [9], and delivery of practice exercises [9,12,18,24].
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Studies that implemented elicitation remotely generally
included some form of instructions, although none reported
these in detail [10].
Experiences with the Analyses and Interpretation of Elicited
Evidence
Considerations on the experiences of analyses and interpretation
of elicited evidence were grouped according to validity assess-
ment, syntheses of multiple beliefs for mathematical aggrega-
tion, deriving smooth prior distributions, and further use of
elicited evidence in decision modeling.
Considerations on validity
Aspects related to validity in applied studies were missingness,
validity checks, and self-reported face validity. Reporting of
missingness was poor: no applications provided recruitment
rates, only a few provided the number of recruited experts who
did not turn up or did not return the elicitation form [10–12,14,24],
and none was explicit about missing responses to individual
questions. No studies dealt with missing responses, either for-
mally or informally.
Three types of validity checks have been implemented. One
study [22] contrasted qualitative and quantitative responses
(internal validity) and found a small number of inconsistent
responses; for example, the statement “I don’t know, this isn’t
my area of research” was accompanied by extremely certain
probability estimates. A second type of validity check compared
the elicited beliefs of multiple experts [9,11,14,23,25,26]. Although
some authors [12,14] valued good agreement, others [9,10]
accepted variation between individuals (on the basis that indi-
vidual beliefs are being requested). Finally, when external evi-
dence was available, this was compared with elicited beliefs
(external validity) [9,12,14,26]. Authors sought agreement, but
when differences arose they cautiously justiﬁed them on the
basis of population differences [12].
Some applications requested feedback from experts on the
ease of completion of the SEE [9,10,24,26], the basis for experts’
answers (to reveal the sources of evidence considered by the
experts and their level of knowledge [10]), or self-reported face
validity [9,10,12,24].
Syntheses of multiple beliefs elicited in mathematical
aggregation
Of the 14 studies that used a mathematical approach to aggre-
gation, 1 did not generate a group estimate and instead used the
responses of each expert individually [14]. Nine linearly pooled,
by averaging individual distributions (with or without weighting;
see earlier). Authors justify this choice on the basis of the lack of
published evidence that more complex methods outperform
linear pooling [10]. Two other studies used the predictive distri-
bution from a random-effects meta-analysis of individual elicited
distributions [18,28], a method arising from statistical method-
ology rather than the wider elicitation literature. Given the
random-effects model results in a combined distribution that
can be more precise than any of the individual distributions,
this pooling method has been deemed inappropriate for use in
MBEE [18].
Generally, inputs to decision models were pooled across
experts, except in one study that ran the model with each of
the individual elicited distributions and linearly pooled resulting
outputs [11].
Deriving smooth prior distribution functions
Some applications were not explicit about how prior distributions
were derived from elicited summaries. Those that were explicit
used parametric distributions (Table 3), with the choice of
distribution either not justiﬁed or based on general MBEE liter-
ature on distribution choice for probabilistic sensitivity analyses
[10]. To ﬁt the distribution (i.e., evaluate the parameters of the
distribution that best ﬁt the empirical distributions elicited from
experts), some applications cited software [11,13] and others cited
the ﬁtting method (e.g., maximum likelihood ﬁtting [10], least
squares [17], and method of moment [9,18]). Goodness of ﬁt was
evaluated either in discussion with the experts [17] or graphically
by superimposing the ﬁtted probability density function on the
histogram [10]. Bojke et al. [18] acknowledged that although the
ﬁt of prespeciﬁed parametric distributions was not always ideal
in their example, methods that allow ﬁtting of nonparametric
distributions are more complex and can complicate further
analyses, particularly when Bayesian updating is further
required, for example, in value of information calculations.
Further use of elicited evidence in decision modeling
Elicited evidence has been seen as a way of characterizing
uncertainty for model parameters or assumptions to inform the
decision to acquire further evidence [9]. In some applications,
elicited evidence was used directly as input to the cost-effective-
ness model [10,12,14,15,20,24]. When external evidence existed
on elicited parameters, some authors presented both sources
separately using scenarios [12,17], whereas others combined
them using Bayesian updating [9,16,21]. The latter is consistent
only under the assumption that the experts did not consider
existing evidence when formulating their judgments [9]. Three
authors [11,14,19] explored use of individual experts’ beliefs and
found that results and associated allocation decisions varied
between experts.
Considerations on Bias
When seeking to gather experts’ opinions, it is important to
consider their potential biases, speciﬁcally motivational or cog-
nitive [30]. Motivational biases relate to conscious or subcon-
scious distortions of judgments because of self-interest.
Cognitive biases are associated with the use of heuristics:
cognitive shortcuts that individuals use when asked for complex
judgments. When such mental processes are faulty, these may
lead to biased judgments.
The potential for bias in expert opinion was recognized in
some SEEs [9,22] with reported attempts to minimize bias in the
design [26]. Two applications made explicit efforts to avoid
recruiting experts that may have motivational biases [13,20].
Two studies provided information on cognitive biases in the
training session [9,24].
Conclusions
In the published applied studies, authors generally recognized
great potential for using elicitation in MBEE, particularly when
evidence was absent (including the early modeling context [13]).
Our critical review demonstrates that reporting is poor (as also
identiﬁed elsewhere [31]), and there is a lack of consensus on
methodology. Given the direct link to healthcare policy decisions,
it is important that methodological guidance speciﬁc to health
technology assessment (HTA) is generated, with consideration of
the constraints inherent to the processes of policy decisions
(such as timelines, budget, and availability of experts). A number
of principles from the elicitation literature are expected to
generalize to the MBEE setting, such as the need for piloting
and training; nevertheless, for many other areas of SEE, it is not
clear that methods used in other disciplines translate to HTA. Our
review highlights a number of speciﬁcities/constraints that can
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shape the development of guidance and target future research
efforts in this area, summarized as follows.
First, there exists important between-expert variation. In
other disciplines, variation is generally linked to different levels
of bias and hence regarded as undesirable, warranting the use of
strategies to reduce or discourage variation, such as consensus
methods. Most applications in MBEE, however, expect wide
variation in the beliefs of multiple experts because of genuine
heterogeneity in the populations experts draw upon. Further
research efforts should examine the origins of variation and
consider how to appropriately reﬂect it.
Second, substantive experts in HTA are health professionals
who may not be trained in quantitative subjects, unlike other
areas of science in which elicitation is used such as engineering
or meteorology. Further research on SEE should consider the
appropriateness of alternative methods of elicitation (e.g., chips
and bins method or bisection method) for the potentially less
normative experts, or how to facilitate the elicitation of complex
parameters, including dependency. Furthermore, elicitation may
have an important role in early modeling in which experts’ beliefs
are required on new technologies. In this case, adaptive skills are
required to allow experts’ substantive expertise (in the disease
area and/or other health care strategies) to be appropriately used.
Further research should focus on how to promote the use of
adaptive skills or how to determine better performing individuals
in this context.
Cost-effectiveness modeling typically requires judgments on a
relatively large number of parameter types (e.g., probabilities,
relative treatment effects, costs, and health-related quality-of-life
scores), and the design and conduct of an SEE may well be
inﬂuenced by what quantities are required. The applications
reviewed here elicit a range of different quantities to inform the
same parameter; they, however, do not draw on evidence or past
experiences speciﬁc to that quantity. Design of future applica-
tions could be aided by a compilation of possible quantities that
can be reasonably used to elicit particular parameters types,
accompanied by guidance on how to ensure that the multiple
quantities elicited in a particular application can be appropriately
used within a decision model.
Perhaps given the direct link to decision making, most applied
examples seek for assurance on the validity of the particular
exercise. It is, however, not clear how such an assessment should
proceed. Examples have used self-reported face-validity assess-
ments, sensitivity analyses, and performance weighting (calibra-
tion). Particularly for performance weighting, despite a growing
(generic) literature discussing the validity of this approach (see,
e.g., Refs. [32–34]), the applied literature struggles with supporting
the methodological choices that need to be made. Although some
means of correcting for poor performance are welcomed, in the
applied literature, concerns have been expressed that this should
not repress expressions of heterogeneity. If SEE is to be used
more systematically in MBEE, further guidance is needed on how
to demonstrate validity.
Finally, although it is generally agreed that SEE should be
designed and conducted in a way that minimizes the use of
heuristics and other sources of bias, there is little integration in
the applied literature of the ﬁndings from behavioral research. A
recent review placing special emphasis on debiasing techniques
[30] is a helpful resource to be reﬂected on in future research.
It is worth noting that our review includes only published
examples, despite SEE being conducted more widely for MBEE.
Moreover, the review is based on analytical reading of the
published articles, and is hence subject to a certain amount of
interpretation. Further research in understanding the landscape
of SEE for MBEE could include structured discussions among
individuals with experience in the area to explore challenges in
past exercises and identify those foreseen in future applications.
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